L’ADN des membres AFSSI
Nos membres sont mis à l’honneur.
L’objectif est de diffuser la richesse des expertises de nos membres en abordant leurs activités et actualités.
À propos de Motac Neuroscience
« We provide highly specialised preclinical research services to pharmaceutical and biotech companies that are developing new treatments for diseases of the central nervous system, particularly neurodegenerative conditions like Parkinson’s disease or other movement and cognitive disorders.
We furnish expert consultancy and laboratory-based research. Studies are performed to high scientific levels and are conform to EU standards.
Our scientific team includes top researchers in the field of neurosciences, renowned both in the academic and private sectors. Our CEO is among the top 1% of researchers that were the most cited by their peers. Our in-house staff is composed of highly trained individuals with an unwavering commitment to discovery, a passion for knowledge, perseverance and resilience combined with a meticulous attention to detail.
We operate in France and in China and have successfully completed hundreds of contract research projects for customers worldwide since 1999. Our clients range from prominent pharmaceutical and biotech companies to SMEs and start-ups.
We operate in France and in China and have successfully completed hundreds of contract research projects for customers worldwide since 1999. Our clients range from prominent pharmaceutical and biotech companies to SMEs and start-ups.
Our services at a glance:
- Expert consultancy to assist and advise with the planning and design of preclinical research within our areas of special expertise. We work hand-in-hand with our clients to find the most suitable model systems, scientific endpoints, and protocol designs.
- Laboratory-based research is undertaken on a flexible basis, ranging from simple contract research to risk-sharing collaborations.
- Partner in several research consortiums, private, academic and institutional organisations. »
Les actualités de Motac Neuroscience
« We are pleased to announce the opening of our brand-new laboratory and animal facility in Beijing, China
This summer, our Beijing team moved to the Biomedical Industries Base in Beijing’s Daxing District.
The 1300 sqm facility houses our NHP colony and is equipped with state-of-the art technology that brings our study performance to a higher level. In addition to the classic batteries, we offer freely behaving kinematics, telemetric EEG studies in freely behaving NHP to analyse sleep disorders, as well as cognition tests using the CANTAB® system assessments that provide scientifically validated, highly sensitive, precise and objective measures of cognitive function, correlated to neural networks. »
Cynbiose and Motac Announce Strategic Partnership to Accelerate Central Nervous System Research
« Cynbiose, a leading preclinical contract research organisation (CRO) specialised in non-human primate (NHP) models, and Motac Neuroscience, a pioneer in neurodegenerative disease research and drug development, are pleased to announce a strategic partnership aimed at accelerating the development of novel therapeutics for central nervous system diseases. »
Membre AFSSI et fier de l’être
Vous êtes membre AFSSI et souhaitez partager votre actualité ?
N’hésitez pas à nous contacter !
